Point72 Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,998,043
| Closed | -$1.31M | – | 1778 |
|
|
2025
Q1 | $1.31M | Sell |
1,998,043
-272,507
| -12% | -$179K | ﹤0.01% | 851 |
|
|
2024
Q4 | $2.32M | Buy |
+2,270,550
| New | +$2.32M | 0.01% | 776 |
|
|
2023
Q3 | – | Sell |
-10,252
| Closed | -$13.3K | – | 2125 |
|
|
2023
Q2 | $13.3K | Sell |
10,252
-27,524
| -73% | -$35.8K | ﹤0.01% | 1330 |
|
|
2023
Q1 | $66.5K | Buy |
+37,776
| New | +$66.5K | ﹤0.01% | 1218 |
|
|
2021
Q2 | – | Sell |
-680,200
| Closed | -$8.52M | – | 1084 |
|
|
2021
Q1 | $8.52M | Buy |
+680,200
| New | +$8.52M | 0.04% | 437 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1027 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 979 |
|
|
2017
Q4 | – | Sell |
-693,300
| Closed | -$10.4M | – | 910 |
|
|
2017
Q3 | $10.4M | Buy |
693,300
+335,595
| +94% | +$5.03M | 0.05% | 314 |
|
|
2017
Q2 | $3.15M | Buy |
+357,705
| New | +$3.15M | 0.02% | 486 |
|
|
2016
Q2 | – | Sell |
-348,200
| Closed | -$2.11M | – | 789 |
|
|
2016
Q1 | $2.11M | Sell |
348,200
-252,100
| -42% | -$1.53M | 0.02% | 492 |
|
|
2015
Q4 | $5.48M | Buy |
600,300
+572,000
| +2,021% | +$5.22M | 0.05% | 376 |
|
|
2015
Q3 | $160K | Sell |
28,300
-292,000
| -91% | -$1.65M | ﹤0.01% | 640 |
|
|
2015
Q2 | $3.55M | Buy |
320,300
+124,200
| +63% | +$1.38M | 0.02% | 462 |
|
|
2015
Q1 | $3.08M | Buy |
196,100
+38,100
| +24% | +$597K | 0.02% | 474 |
|
|
2014
Q4 | $2.4M | Sell |
158,000
-483,500
| -75% | -$7.35M | 0.02% | 491 |
|
|
2014
Q3 | $6.92M | Sell |
641,500
-147,400
| -19% | -$1.59M | 0.05% | 319 |
|
|
2014
Q2 | $12M | Buy |
+788,900
| New | +$12M | 0.08% | 271 |
|